Schedule 13G ownership disclosure

PLIANT THERAPEUTICS INC

Common stock, par value $0.0001 per share (the "Shares") · CUSIP: 729139105

Event date: 2026-01-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Citadel Advisors LLC

    Shares: 2,099,798.00 · Class: 3.4%

  • Citadel Advisors Holdings LP

    Shares: 2,099,798.00 · Class: 3.4%

  • Citadel GP LLC

    Shares: 2,099,798.00 · Class: 3.4%

  • Citadel Securities LLC

    Shares: 863,391.00 · Class: 1.4%

  • Citadel Securities Group LP

    Shares: 892,117.00 · Class: 1.5%

  • Citadel Securities GP LLC

    Shares: 892,117.00 · Class: 1.5%

  • Kenneth Griffin

    Shares: 2,991,915.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-005905
Form type
SCHEDULE 13G
Filer
CITADEL ADVISORS LLC
CIK
CIK 1423053
Filed
Jan 22, 2026
Reporting period
Jan 14, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub